1112 6-Mercaptopurine Induced Symptomatic Hypoglycaemia in Children with Acute Lymphoblastic Leukaemia

被引：0
|
作者：
M White
L Storey
C Costigan
O Smith
机构：
[1] Diabetes & Endocrinology,
[2] Haematology,undefined
[3] Our Lady's Children's Hospital,undefined
来源：
Pediatric Research | 2010年 / 68卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background & Aims: Although the most common cause of SH in paediatric acute lymphoblastic leukaemia (ALL) is over-treatment of hyperglycaemia with insulin, it is also associated with thiopurine usage. The aim of this study was to document the incidence of 6-mercaptopurine (6MP)-related symptomatic hypoglycaemia (SH) in paediatric patients undergoing maintenance treatment for ALL.
引用
收藏
页码：551 / 552
页数：1
相关论文
共 50 条
  • [1] 6-MERCAPTOPURINE INDUCED SYMPTOMATIC HYPOGLYCAEMIA IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKAEMIA
    White, M.
    Storey, L.
    Costigan, C.
    Smith, O.
    PEDIATRIC RESEARCH, 2010, 68 : 551 - 552
  • [2] Precision therapy of 6-mercaptopurine in Chinese children with acute lymphoblastic leukaemia
    Zhou, Yue
    Wang, Li
    Zhai, Xiao-Ying
    Wen, Li
    Tang, Fang
    Yang, Fan
    Liu, Xi-Ting
    Dong, Lei
    Zhi, Li-Juan
    Shi, Hai-Yan
    Hao, Guo-Xiang
    Zheng, Yi
    Jacqz-Aigrain, Evelyne
    Wang, Tian-You
    Zhao, Wei
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 86 (08) : 1519 - 1527
  • [3] 6-MERCAPTOPURINE IN ACUTE LEUKAEMIA
    HAYHOE, FGJ
    LANCET, 1955, 2 (OCT29): : 903 - 905
  • [4] Pharmacokinetics and distribution of 6-mercaptopurine administered intravenously in children with lymphoblastic leukaemia
    JacqzAigrain, E
    Nafa, S
    Medard, Y
    Bessa, E
    Lescoeur, B
    Vilmer, E
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 53 (01) : 71 - 74
  • [5] Pharmacokinetics and distribution of 6-mercaptopurine administered intravenously in children with lymphoblastic leukaemia
    E. Jacqz-Aigrain
    S. Nafa
    Y. Médard
    E. Bessa
    B. Lescoeur
    E. Vilmer
    European Journal of Clinical Pharmacology, 1997, 53 : 71 - 74
  • [6] Adherence to 6-Mercaptopurine in children and adolescents with Acute Lymphoblastic Leukemia
    Alsous, Mervat
    Abu Farha, Rana
    Alefishat, Eman
    Al Omar, Suha
    Momani, Deema
    Gharabli, Alia
    McElnay, James
    Horne, Robert
    Rihani, Rawad
    PLOS ONE, 2017, 12 (09):
  • [7] Pharmacogenetics of 6-mercaptopurine in a black Zimbabwean cohort treated for acute lymphoblastic leukaemia
    Chikondowa, Pageneck
    Munkombwe, Derick
    Chikwambi, Zedias
    Kuona, Patience
    Masimirembwa, Collen
    PHARMACOGENOMICS, 2023, 24 (08) : 449 - 457
  • [8] Should TPMT genotype and activity be used to monitor 6-mercaptopurine treatment in children with acute lymphoblastic leukaemia?
    Fakhoury, M.
    Andreu-Gallien, J.
    Mahr, A.
    Medard, Y.
    Azougagh, S.
    Vilmer, E.
    Jacqz-Aigrain, E.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2007, 32 (06) : 633 - 639
  • [9] PREGNANCY IN ACUTE LEUKAEMIA TREATED WITH 6-MERCAPTOPURINE
    MERSKEY, C
    RIGAL, W
    LANCET, 1956, 271 (DEC15): : 1268 - 1269
  • [10] Language, 6-mercaptopurine adherence, and relapse in children with acute lymphoblastic leukemia
    Robles, Joanna
    Chen, Yanjun
    Hageman, Lindsey
    Aristizabal, Paula
    Landier, Wendy
    Bhatia, Smita
    Wadhwa, Aman
    JNCI CANCER SPECTRUM, 2024, 8 (05)
12345